- Home
- LXEO vs GNE Comparison
LXEO vs GNE Comparison
Compare LXEO & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LXEO | GNE |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Power Generation |
| Sector | | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.5M | 359.1M |
| IPO Year | 2023 | 2011 |
Fundamental Metrics
Financial Performance| Metric | LXEO | GNE |
|---|---|---|
| Price | $4.88 | $15.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $18.44 | $16.00 |
| AVG Volume (30 Days) | ★ 910.6K | 63.0K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | 39.81 | ★ 95.65 |
| EPS | N/A | ★ 0.54 |
| Revenue | $654,000.00 | ★ $425,202,000.00 |
| Revenue This Year | N/A | $17.49 |
| Revenue Next Year | N/A | $7.07 |
| P/E Ratio | ★ N/A | $27.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.99 | $12.69 |
| 52 Week High | $10.99 | $16.28 |
Technical Indicators
Market Signals| Indicator | LXEO | GNE |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 60.91 |
| Support Level | $4.39 | $13.45 |
| Resistance Level | $5.01 | $15.83 |
| Average True Range (ATR) | 0.31 | 0.43 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 54.39 | 74.43 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.